Amgen vs Volkswagen: Founders, CEOs and History
Amgen was founded in 1980 by George B. Rathmann, William K. Bowes Jr. and is led by Robert A. Bradway. Volkswagen was founded in 1937 by Ferdinand Porsche and is led by Oliver Blume.
Company facts
Amgen
- Founded
- 1980
- Headquarters
- Thousand Oaks, California
- Current CEO
- Robert A. Bradway
- Employees
- 31,500
Volkswagen
- Founded
- 1937
- Headquarters
- Wolfsburg, Germany
- Current CEO
- Oliver Blume
- Employees
- 663,000
Founders
Amgen
George B. Rathmann
Amgen, originally incorporated as Applied Molecular Genetics, was founded in 1980 not by a single scientist, but by a calculated syndicate of venture capitalists and academics trying to commercialize the brand-new science of recombinant DNA.
William K. Bowes Jr.
William K. Bowes Jr. Was the venture capital strategist whose vision catalyzed Amgen's formation.
Volkswagen
Ferdinand Porsche
Ferdinand Porsche (1875-1951) was an Austrian-born automotive engineer who had worked for Lohner, Austro-Daimler and Daimler-Benz before opening his own design office in Stuttgart in 1931.
CEOs and their tenures
Amgen
- George B. Rathmann1980–1988
Chief Executive Officer
George Rathmann, a physical chemist who had run research and development at Abbott Laboratories, was named Amgen's first chief executive in 1980 and worked from a small trailer so that laboratory space could go to scientists.
Source - Gordon M. Binder1988–2000
Chief Executive Officer
Gordon Binder joined Amgen as chief financial officer in 1982 and led its June 1983 initial public offering.
Source - Kevin W. Sharer2000–2012
Chief Executive Officer
Kevin Sharer joined Amgen in 1992 as president and chief operating officer and became chairman and chief executive in 2000.
Source - Robert A. Bradway2012–present
Chairman and Chief Executive Officer
Robert Bradway became chief executive on May 23, 2012, succeeding Kevin Sharer as the fourth CEO in Amgen's history, and added the chairmanship at the start of 2013.
Source
Volkswagen
- Hermann Münch1946–1947
Chief Executive Officer
Early executive involved in the incredibly complex immediate post-war administration of the completely destroyed factory under British military control.
Source - Heinrich Nordhoff1948–1968
Chief Executive Officer
The absolute legendary post-war architect who took the ruins of the VW factory and transformed the Beetle into a massive, globally beloved cultural icon and economic miracle.
Source - Kurt Lotz1968–1971
Chief Executive Officer
Early post-war leader who began the critical process of diversifying VW's lineup beyond relying entirely on a single model (the Beetle).
Source - Rudolf Leiding1971–1975
Chief Executive Officer
Crucial CEO who managed the extremely difficult, highly risky transition away from the iconic but severely outdated Beetle toward modern, front-wheel-drive water-cooled cars (like the Golf).
Source - Toni Schmücker1975–1982
Chief Executive Officer
Guided the company through the severe financial crises of the 1970s, ensuring the successful launch and massive adoption of the original VW Golf.
Source - Carl Hahn1982–1993
Chief Executive Officer
As CEO in the 1980s, he executed the massive, highly strategic acquisitions of SEAT and Skoda, laying the foundation for VW's absolute dominance in Europe.
Source - Ferdinand Piëch1993–2002
Chief Executive Officer
As the legendary, absolutely ruthless patriarch (and grandson of Ferdinand Porsche), he transformed VW from a struggling mass-market brand into the most powerful automotive conglomerate on Earth.
Source - Bernd Pischetsrieder2002–2006
Chief Executive Officer
Serving as CEO from 2002 to 2006, he oversaw the incredibly complex integration of massive luxury brands like Bugatti and Bentley into the VW Group portfolio.
Source - Martin Winterkorn2007–2015
Chief Executive Officer
As the notoriously demanding, absolutely feared CEO, he oversaw massive global expansion but fostered a culture of absolute terror that led engineers to cheat rather than admit failure.
Source - Matthias Müller2015–2018
Chief Executive Officer
As CEO during the darkest period in modern VW history, he initiated the massive cultural purge of the toxic, highly secretive engineering culture that caused the cheating scandal.
Source - Herbert Diess2018–2022
Chief Executive Officer
Serving as CEO, he forcefully dragged the massive, highly bureaucratic legacy automaker into the Tesla era, though his abrasive style alienated the powerful Porsche-Piëch families.
Source - Oliver Blume2022–present
Chairman of the Board of Management
He also ran Porsche AG alongside the group role until Michael Leiters took over as Porsche CEO on January 1, 2026, leaving Blume focused on Volkswagen Group.
Source
Timeline: Amgen and Volkswagen side by side
1937Volkswagen
Volkswagen founded
Volkswagen was founded under the German Labour Front as part of a state-directed people's car program.
1945Volkswagen
Wolfsburg restarted
British military administration helped restart peacetime production at Wolfsburg after World War II.
1965Volkswagen
Audi foundation added
Volkswagen acquired Auto Union from Daimler-Benz, creating the foundation for modern Audi.
1974Volkswagen
Golf production begins
The Golf gave Volkswagen a modern front-engine, front-wheel-drive compact platform after the Beetle era.
1980Amgen
Applied Molecular Genetics is incorporated
Applied Molecular Genetics (AMGen) was incorporated on April 8, 1980 in Thousand Oaks, California, as the idea of venture capitalist William K. Bowes Jr. and a group of scientific collaborators.
1983Amgen
Nasdaq listing and the erythropoietin clone
Amgen completed its initial public offering on June 17, 1983, raising nearly US$40 million under chief financial officer Gordon Binder, and formally shortened its name to Amgen.
1984Amgen
Kirin-Amgen joint venture formed
Amgen and Kirin Brewery Company of Japan formed Kirin-Amgen in 1984 as a joint venture for the worldwide commercialization of erythropoietin.
1985Amgen
G-CSF cloned, leading to Neupogen
While Fu-Kuen Lin's team worked on erythropoietin, researcher Larry Souza and his group cloned and expressed human granulocyte colony-stimulating factor in 1985.
1989Amgen
FDA approves Epogen
The FDA approved Epogen (epoetin alfa) on June 1, 1989 for anemia in patients with chronic kidney failure on dialysis. It was the first commercial recombinant human erythropoietin. Epogen's U.S.
1991Amgen
Neupogen approved, giving Amgen a second franchise
The FDA approved Neupogen (filgrastim) in February 1991. By stimulating white blood cell production it reduced the risk of infection in cancer patients with chemotherapy-induced neutropenia.
1991Amgen
Amgen wins the erythropoietin patent fight
On March 6, 1991 the U.S. Court of Appeals for the Federal Circuit upheld the Kirin-Amgen erythropoietin patent and ruled against Genetics Institute in Amgen v. Chugai Pharmaceutical and Genetics Institute.
2001Amgen
FDA approves Aranesp, the longer-acting EPO
Aranesp (darbepoetin alfa), an erythropoietin analogue with modified glycosylation and a longer half-life, was approved in 2001. Less frequent dosing than Epogen improved convenience and gave Amgen a newer, higher-priced product to migrate patients toward.
2002Amgen
US$16 billion Immunex acquisition brings Enbrel in-house
Amgen completed its acquisition of Immunex Corporation on July 16, 2002, the largest biotechnology deal to that point at about US$16 billion in stock and cash.
2010Amgen
Prolia and XGEVA create the bone health franchise
The FDA approved Prolia (denosumab) for postmenopausal osteoporosis in June 2010 and XGEVA, the same molecule at a higher dose, for prevention of skeletal-related events in cancer patients in November 2010.
2012Volkswagen
Porsche consolidated
Porsche became a controlled sport-luxury profit anchor within Volkswagen Group.
2015Volkswagen
Matthias Müller becomes CEO
Matthias Müller became CEO of Volkswagen Aktiengesellschaft in 2015. Chief executive of Volkswagen Aktiengesellschaft from 2015 to 2018.
2015Volkswagen
Emissions Scandal
US regulators accused Volkswagen in September 2015 of fitting diesel cars with software that cheated emissions tests.
2018Volkswagen
Herbert Diess becomes CEO
Herbert Diess became CEO of Volkswagen Aktiengesellschaft in 2018. Chief executive of Volkswagen Aktiengesellschaft from 2018 to 2022.
2019Amgen
US$13.4 billion purchase of Otezla from Celgene
Amgen agreed in August 2019 to buy worldwide rights to Otezla (apremilast) from Celgene for US$13.4 billion in cash, or about US$11.2 billion net of the present value of US$2.2 billion of anticipated future cash tax benefits, and closed on November 21, 2019.
2020Amgen
Amgen joins the Dow Jones Industrial Average
Amgen replaced Pfizer in the Dow Jones Industrial Average on August 31, 2020, becoming one of the thirty components in the index. Inclusion recognized the scale Amgen had reached and added passive demand from Dow-tracking funds.
2022Volkswagen
Oliver Blume becomes chairman
Oliver Blume became chairman of Volkswagen Aktiengesellschaft in 2022. He also ran Porsche AG alongside the group role until Michael Leiters took over as Porsche CEO on January 1, 2026, leaving Blume focused on Volkswagen Group.
2023Amgen
US$27.8 billion Horizon Therapeutics acquisition closes
Amgen completed the acquisition of Horizon Therapeutics plc on October 6, 2023 for US$116.50 per share in cash, an equity value of about US$27.8 billion, after settling FTC litigation with a behavioral consent decree.
2024Amgen
Imdelltra becomes the first T-cell engager for small cell lung cancer
The FDA granted accelerated approval to tarlatamab, sold as Imdelltra, on May 16, 2024 for extensive stage small cell lung cancer that has progressed on or after platinum-based chemotherapy.
2024Volkswagen
Rivian software joint venture
Volkswagen and Rivian launched a software joint venture targeting next-generation electrical architecture.
2025Amgen
VESALIUS-CV extends the Repatha case to primary prevention
In November 2025 Amgen reported Phase 3 VESALIUS-CV results in more than 12,000 patients with atherosclerosis or diabetes but no prior heart attack or stroke.
2025Volkswagen
Revenue reaches ~$364B (EUR321.9B)
Volkswagen reported ~$364 billion (EUR321.9 billion) in sales revenue, ~$10.1 billion (EUR8.9 billion) in operating result, and 8.984 million deliveries.
2026Amgen
Medicare price setting reaches Enbrel and Otezla
Enbrel's negotiated Medicare price under the Inflation Reduction Act took effect on January 1, 2026, after it was named in the first round of ten drugs selected for negotiation.
Acquisitions
Amgen
- Horizon Therapeutics plc2023$27.8B
- ChemoCentryx, Inc.2022$3.7B
- Five Prime Therapeutics2021$1.9B
- Celgene Otezla Business2019$13.4B
- Onyx Pharmaceuticals, Inc.2013$10.4B
- DeCODE Genetics2012$415M
Volkswagen
- Porsche AG2012Undisclosed
- Bentley Motors1998Undisclosed
- Auto Union / Audi1965Undisclosed
Questions about Amgen vs Volkswagen
Who is the CEO of Amgen Inc. and Volkswagen Aktiengesellschaft?
Amgen Inc. is led by Robert A. Bradway and Volkswagen Aktiengesellschaft is led by Oliver Blume. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Amgen Inc. founded vs Volkswagen Aktiengesellschaft?
Volkswagen Aktiengesellschaft was founded in 1937 — 43 years before Amgen Inc., which was founded in 1980. Volkswagen Aktiengesellschaft's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Amgen Inc..
How many employees does Amgen Inc. have compared to Volkswagen Aktiengesellschaft?
Amgen Inc. employs approximately 31,500 people, while Volkswagen Aktiengesellschaft employs approximately 663,000. Volkswagen Aktiengesellschaft has the larger workforce at 663,000 employees, compared to Amgen Inc.'s 31,500. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Amgen Inc. and Volkswagen Aktiengesellschaft headquartered?
Amgen Inc. is headquartered in United States and Volkswagen Aktiengesellschaft is headquartered in Germany. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.
Who founded Amgen Inc. and Volkswagen Aktiengesellschaft?
Amgen Inc. was founded by George B. Rathmann, William K. Bowes Jr.. Volkswagen Aktiengesellschaft was founded by Ferdinand Porsche.
Which company has a longer operating history — Amgen Inc. or Volkswagen Aktiengesellschaft?
Volkswagen Aktiengesellschaft has been operating for approximately 89 years, making it the more established of the two companies. Amgen Inc. has been in operation for around 46 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Amgen vs Volkswagen overview